Advances in DNA- and RNA-Based Oncolytic Viral Therapeutics and Immunotherapies
Open Access
- 27 April 2022
- journal article
- review article
- Published by MDPI AG in Applied Microbiology
- Vol. 2 (2) , 319-329
Abstract
The role of viruses has been studied extensively for use as curative cancer therapies. However, the natural immunogenicity of viruses and their interaction with the host’s immune system needs to be examined to determine the full effectiveness of the viral treatment. The prevalence of cancer is increasing globally, and treatments are needed to support the increasing body of patient care. Oncolytic viral therapies used existing pathogenic viruses, which are genetically modified to not cause disease in humans when administered using a vaccine viral vector. Immunotherapies are another avenue of recent interest that has gained much traction. This review will discuss oncolytic viral approaches using three DNA-based viruses, including herpes simplex virus (HSV), vaccinia virus, and adenovirus; as well as four RNA-based viruses, including reovirus, Newcastle disease virus (NDV), poliovirus, and measles virus (MV). It also examines the novel field of cancer-based immunotherapies.Keywords
This publication has 39 references indexed in Scilit:
- Vector Design for Improved DNA Vaccine Efficacy, Safety and ProductionVaccines, 2013
- Complete Genome Sequence of Newcastle Disease Virus Mesogenic Vaccine Strain R2B from IndiaJournal of Virology, 2012
- Reovirus Virotherapy Overrides Tumor Antigen Presentation Evasion and Promotes Protective Antitumor ImmunityMolecular Cancer Therapeutics, 2010
- Recombinant Oncolytic Poliovirus Eliminates Glioma In Vivo Without Genetic Adaptation to a Pathogenic PhenotypeMolecular Therapy, 2008
- Herpes Vector-Mediated Gene Transfer in Treatment of Diseases of the Nervous SystemAnnual Review of Microbiology, 2004
- Oncolytic measles viruses for cancer therapyExpert Opinion on Biological Therapy, 2004
- High CD46 Receptor Density Determines Preferential Killing of Tumor Cells by Oncolytic Measles VirusCancer Research, 2004
- Cancer immunotherapy with mRNA‐transfected dendritic cellsImmunological Reviews, 2004
- Oncolytic herpes simplex virus vectors for cancer virotherapyCancer Gene Therapy, 2002
- Postoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccineCancer Immunology, Immunotherapy, 1990